Clinical Trials Browser

Pituitary Neoplasms × Rosiglitazone × Clear all

NCT00616642 2020-08-14

Rosiglitazone in Treating Patients With Pituitary Tumors

Phase 2 Terminated

1 enrolled 4 charts

Pituitary Neoplasms, Central Nervous System Neoplasms

NCT03309319 2017-10-13

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Phase NA Unknown

Pituitary Neoplasms